CD4-Positive T-Lymphocytes
"CD4-Positive T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.
| Descriptor ID |
D015496
|
| MeSH Number(s) |
A11.118.637.555.567.569.200 A15.145.229.637.555.567.569.200 A15.382.490.555.567.569.200
|
| Concept/Terms |
CD4-Positive T-Lymphocytes- CD4-Positive T-Lymphocytes
- CD4 Positive T Lymphocytes
- CD4-Positive T-Lymphocyte
- T-Lymphocyte, CD4-Positive
- T-Lymphocytes, CD4-Positive
- CD4-Positive Lymphocytes
- CD4-Positive Lymphocyte
- Lymphocyte, CD4-Positive
- Lymphocytes, CD4-Positive
- T4 Cells
- T4 Cell
- T4 Lymphocytes
- T4 Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "CD4-Positive T-Lymphocytes".
Below are MeSH descriptors whose meaning is more specific than "CD4-Positive T-Lymphocytes".
This graph shows the total number of publications written about "CD4-Positive T-Lymphocytes" by people in this website by year, and whether "CD4-Positive T-Lymphocytes" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 5 | 2 | 7 | | 1997 | 2 | 0 | 2 | | 1998 | 9 | 6 | 15 | | 1999 | 6 | 5 | 11 | | 2000 | 8 | 2 | 10 | | 2001 | 5 | 5 | 10 | | 2002 | 9 | 6 | 15 | | 2003 | 7 | 4 | 11 | | 2004 | 12 | 9 | 21 | | 2005 | 13 | 10 | 23 | | 2006 | 16 | 14 | 30 | | 2007 | 14 | 13 | 27 | | 2008 | 17 | 7 | 24 | | 2009 | 17 | 6 | 23 | | 2010 | 12 | 12 | 24 | | 2011 | 19 | 10 | 29 | | 2012 | 13 | 15 | 28 | | 2013 | 19 | 9 | 28 | | 2014 | 31 | 13 | 44 | | 2015 | 19 | 13 | 32 | | 2016 | 14 | 14 | 28 | | 2017 | 15 | 15 | 30 | | 2018 | 10 | 9 | 19 | | 2019 | 17 | 13 | 30 | | 2020 | 11 | 8 | 19 | | 2021 | 17 | 16 | 33 | | 2022 | 3 | 10 | 13 | | 2023 | 2 | 9 | 11 | | 2024 | 5 | 7 | 12 | | 2025 | 9 | 8 | 17 | | 2026 | 13 | 8 | 21 |
To return to the timeline, click here.
Below are the most recent publications written about "CD4-Positive T-Lymphocytes" by people in Profiles.
-
Douglas K, Delong T. Hybrid Insulin Peptides in Type 1 Diabetes: How They Form and Why They Matter. Immunol Rev. 2026 Oct; 343(1):e70185.
-
Guo K, Dillon SM, Meneses EC, Barrett BS, Norman A, Mickens KL, Morrison JH, Dittmer U, Sutter K, Poeschla EM, Kechris K, Wilson CC, Santiago ML. Interferome profiling in the blood links IFNa5-Mucin-1 axis to HIV-1 pathogenesis. J Virol. 2026 Oct 20; 100(10):e0108926.
-
Sawada K, Oates JR, Kimura M, Stankiewicz TE, Eom J, Alarcon PC, Chung H, Damen MSMA, Ulanowicz CJ, Wayland JL, Williams Fonner ESO, Anderson CC, Cuervo-Jimenez HK, Pearson AM, Wang Y, Salomonis N, Troutman TD, Reisz JA, Rathmell JC, Szabo S, Helmrath MA, Takebe T, Moreno-Fernandez ME, Divanovic S. Glutamine metabolism as a rheostat of CD4+ T cell pathogenic function in metabolic dysfunction-associated steatotic liver disease. Cell Metab. 2026 Oct 06; 38(10):2090-2110.e9.
-
Hanna SJ, Robinson EJ, Thayer TC, Nakayama M, Landry L, Andrews R, Dolton G, Davies J, Williams E, Pearson JA, Sewell AK, Narendran P, Wraith DC, Howell A, Young P, Hart M, Lindqvist A, Wong FS, Tree TI, Dayan CM, Tatovic D. Tracking GAD-specific T cell expansions in type 1 diabetes by intradermal GAD-alum challenge. JCI Insight. 2026 Oct 22; 11(20).
-
Maeda K, Campbell PL, Wu Q, Tsou PS, Cooney LA, Mao-Draayer Y, Fox DA, Gurrea-Rubio M. Anti-CD6 monoclonal antibody UMCD6 induces CD6 internalization, remodels costimulatory receptor availability, and modulates CD4+ T-cell activation. Front Immunol. 2026; 17:1918840.
-
Haskins K, Delong T, DiLisio JE, Baker RL. Hybrid Insulin Peptides as Antigens and Tolerogens for Pathogenic T Cells in Autoimmune Diabetes. Immunol Rev. 2026 Aug; 341(1):e70142.
-
Wenzlau JM, Mangold K, Nicholson K, Dang M, Hohenstein AC, Douglas KS, DiLisio JE, Powell R, Delong T, Haskins K, Baker RL. A novel region of the insulin B9-23 sequence is targeted by a HIP-reactive diabetogenic T cell clone. Front Immunol. 2026; 17:1837267.
-
Mickael C, Fonseca Balladares DC, Kumar R, Lee MH, Nolan K, Sanders L, Tuscan KJ, Prasad R, Londono P, Oliveira FP, Pyper KB, Molofsky AB, Tuder RM, Stenmark KR, Graham BB. Role of CD4+ T cell mannose binding lectin in Schistosoma-induced pulmonary hypertension. JCI Insight. 2026 Sep 08; 11(17).
-
King HAD, Subra C, Tourtellott E, Swafford I, Basu S, Rossman M, Phillips L, Obarorakpor N, Ding S, Ferrari MG, Beck Z, Lewitus E, Bai H, Dong M, Slike BM, Kim D, Dussupt V, Mendez-Rivera L, Eisel N, Zhang L, Williams LD, Tomaras GD, Finzi A, Matyas GR, Krebs SJ, Rolland M, Rao M, Paquin-Proulx D, Bolton DL. Rapid and robust immune response boosting with potent, next-generation adjuvant in viral vector-primed primates. J Virol. 2026 Aug 18; 100(8):e0038926.
-
Freeman ML, Fitzgerald W, Clagett BM, O'Hare KA, Jonnalagadda V, Wilson BM, Margolis L, Wu K, Tassiopoulos K, Shive CL, Erlandson KM. Frailty in People with HIV Is Linked to Inflammation, Bone Health, and T-Cell Exhaustion. J Infect Dis. 2026 Jun 16; 233(6):995-1004.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|